This topic contains a solution. Click here to go to the answer

Author Question: To prevent life-threatening events from rapid withdrawal of a beta blocker: 1. The dosage ... (Read 85 times)

misspop

  • Hero Member
  • *****
  • Posts: 540
To prevent life-threatening events from rapid withdrawal of a beta blocker:
 
  1. The dosage interval should be increased by 1 hour each day.
  2. An alpha blocker should be added to the treatment regimen before withdrawal.
  3. The dosage should be tapered over a period of weeks.
  4. The dosage should be decreased by one-half every 4 days.

Question 2

Carvedilol is heavily metabolized by CYP2D6 and 2C9, resulting in drug interactions with which of the following drug classes?
 
  1. Histamine 2 blockers
  2. Quinolones
  3. Serotonin re-uptake inhibitors
  4. All of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

joanwhite

  • Sr. Member
  • ****
  • Posts: 308
Answer to Question 1

4

Answer to Question 2

4



misspop

  • Hero Member
  • *****
  • Posts: 540
Both answers were spot on, thank you once again



joanwhite

  • Sr. Member
  • ****
  • Posts: 308

 

Did you know?

Signs and symptoms of a drug overdose include losing consciousness, fever or sweating, breathing problems, abnormal pulse, and changes in skin color.

Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library